Tools for connectomics in C.elegans

Nicholas Barry at the MIT Media Lab used vivoPHIX™ for preparing nematodes for fluorescence studies in work titled “Tools for connectomics in C.elegans“ The simplicity of the 302-node nervous system of the nematode C.elegans, makes this an attractive model organism for neuroscientists, however more work is required to fully understand and characterise the function of… Continue reading Tools for connectomics in C.elegans

Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19

Mantke et al., demonstrated the use of virusPHIX-P9™ for stablising SARS-CoV-2 Antigen and use by 258 participants across 27 countries for Lateral flow rapid antigen tests, automated point-of-care-tests and laboratory ELISA / immunoassays.    Antigen testing has become integral in the ongoing monitoring and detection of COVID-19.  Independent and extensive comparative evaluations using data from external… Continue reading Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19

Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications

Loop-mediated isothermal amplification (LAMP) has played a crucial role in filling global COVID-19 testing need.  ln this study, Moore et al., discuss the use of virusPHIX™ for the stablisation and inactivation of SARS-CoV-2 and eventual detection by LAMP amplification.  Read the research

Daily rhythms in gene expression of the human parasite Schistosoma mansoni

Kate Rawlinson at the Sanger Institute, Hinxton, UK used vivoPHIX™ to preserve RNA of the Schistosome parasite for a ‘circadian clock study’.  Due to the Earth’s natural rotations, 24 hour biological rythms are present in most species on Earth. The team addressed these questions using the human blood fluke Schistosoma mansoni that lives in the… Continue reading Daily rhythms in gene expression of the human parasite Schistosoma mansoni

Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

In this paper, Killip et al., (Public Health England) have used RNAssist’s virusPHIX™ reagents to demonstrate SARS-CoV-2 inactivation.  We were asked by the UK Department for Health and Social Care to participate in this study for non-guanidine reagents (guanidine being potentially very toxic but commonly used for inactivation). It was great to see these excellent results… Continue reading Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

We’re attending the mRNA – Based Therapeutics Summit

We are delighted to attend the 2nd Annual mRNA-Based Therapeutics Summit 24th-26th January 2023 in Berlin.  Following the successful development of vaccines against Covid-19,  biopharma hopes to deploy mRNA-based therapies to combat many other diseases in oncology, rare disorders, and beyond. The meeting is an ideal opportunity for us to meet colleagues from across the… Continue reading We’re attending the mRNA – Based Therapeutics Summit